Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to EmpoweRx Inc. in September, 2022 for $243,500.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DP006691-01 | Phase I | 243,500 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Ashwin-Ushas Corporation in September, 2020 for $149,989.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43OH012080-01A1 | Phase I | 149,989 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Dfusion Inc. in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43CE003169-01 | Phase I | 225,000 | September 18, 2019 | |||||||
A SBIR Phase I contract was awarded to Innovation Research And Training, Inc. in September, 2018 for $149,999.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DD001219-01 | Phase I | 149,999 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to Aster Labs, Inc. in August, 2019 for $658,591.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R44DD001286-01A1 | Phase II | 658,591 | August 26, 2019 | |||||||
A SBIR Phase I contract was awarded to CELL PODIUM LLC in August, 2020 for $150,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43OH012129-01 | Phase I | 150,000 | August 1, 2020 | |||||||
A SBIR Phase I contract was awarded to NATIONAL HEALTH PROMOTION ASSOCIATES, INC in September, 2020 for $241,554.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43CE003173-01 | Phase I | 241,554 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to Jan Biotech, Inc. in September, 2022 for $275,766.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43GH002389-01A1 | Phase I | 275,766 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Ceres Nanosciences in September, 2020 for $243,500.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001142-01 | Phase I | 243,500 | September 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Seacoast Science, Inc. in August, 2021 for $531,097.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 2R44OH011935-02 | Phase II | 531,097 | August 1, 2021 | |||||||
A SBIR Phase I contract was awarded to OpenLattice in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43CE002937-01 | Phase I | 225,000 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to GENETAG TECHNOLOGY, INC. in August, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001128-01A1 | Phase I | 225,000 | August 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Innovation Research And Training, Inc. in September, 2020 for $449,883.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 2R44CE003171-02 | Phase II | 449,883 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to Versatope Therapeutics in September, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001127-01A1 | Phase I | 225,000 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to MAKESafe Tools in September, 2019 for $149,432.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43OH011792-01A1 | Phase I | 149,432 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Medical Decision Logic in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DD001220-01 | Phase I | 225,000 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to SPEECH TECHNOLOGY/APPLIED RESEARCH CORP. in September, 2020 for $149,949.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43OH012084-01 | Phase I | 149,949 | September 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Health Outcomes in September, 2020 for $995,215.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 2R44DD001232-02 | Phase II | 995,215 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to Oregon Research Behavioral Intervention Strategies, INC in August, 2019 for $224,996.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DP006495-01 | Phase I | 224,996 | August 23, 2019 | |||||||
A SBIR Phase I contract was awarded to Piezobiomembrane, Inc. in September, 2022 for $276,415.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43OH012495-01 | Phase I | 276,415 | September 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Charles River Analytics in September, 2021 for $243,459.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DP006690-01 | Phase I | 243,459 | September 30, 2021 | |||||||
A SBIR Phase I contract was awarded to Ocean Nanotech, LLC in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43PS005187-01 | Phase I | 225,000 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to Blumio, Inc. in September, 2018 for $222,741.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43DP006419-01A1 | Phase I | 222,741 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Universal Stabilization Technologies, Inc. in September, 2018 for $221,743.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43IP001107-01 | Phase I | 221,743 | September 30, 2018 | |||||||
A SBIR Phase I contract was awarded to GAIA MEDICAL INSTITUTE, LLC, THE in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43CE003070-01 | Phase I | 225,000 | September 30, 2018 |